Brain Advance Access originally published online on August 22, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Brain, Vol. 126, No. 10, 2153-2163,
October 2003
© 2003 Guarantors of Brain
doi: 10.1093/brain/awg229
300-Hz subthalamic oscillations in Parkinson’s disease
1 Department of Neurological Sciences, Università di Milano, IRCCS Ospedale Maggiore di Milano, 2 Department of Biomedical Engineering, Politecnico di Milano, 3 Department of Clinical Neurology, Ospedale San Paolo, Milano, Italy and 4 School of Biomedical Engineering, Science and Health Systems, Drexel University, Philadelphia, PA, USA *These two authors equally contributed to this work.
Correspondence to: Professor Alberto Priori, Dipartimento di Scienze Neurologiche, Clinica Neurologica, Padiglione Ponti, Ospedale Maggiore Policlinico, Via F. Sforza 35, Milano, 20122, Italy E-mail: alberto.priori{at}unimi.it
Despite several studies and models, much remains unclear about how the human basal ganglia operate. Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is an effective treatment for complicated Parkinson’s disease, but how DBS acts also remains unknown. The clinical benefit of DBS at frequencies >100 Hz suggests the possible importance of neural rhythms operating at frequencies higher than the range normally considered for basal ganglia processing (<100 Hz). The electrodes implanted for DBS also offer the opportunity to record neural activity from the human basal ganglia. This study aimed to assess whether oscillations at frequencies >100 Hz operate in the human STN. While recording local field potentials from the STN of nine patients with Parkinson’s disease through DBS electrodes, we found a dopamine- and movement-dependent 300-Hz rhythm. At rest, and in the absence of dopaminergic medication, in most cases (eight out of 11 nuclei) the 100–1000 Hz band showed no consistent rhythm. Levodopa administration elicited (or markedly increased) a 300-Hz rhythm at rest [(mean ± SD) central frequency: 319 ± 33 Hz; bandwidth: 72 ± 21 Hz; power increase (after medication – before medication)/before medication: 1.30 ± 1.25; n = 11, P = 0.00098]. The 300-Hz rhythm was also increased by apomorphine, but not by orphenadrine. The 300-Hz rhythm was modulated by voluntary movement. Before levodopa administration, movement-related power increase in the 300-Hz rhythm was variably present in different subjects, whereas after levodopa it became a robust phenomenon [before 0.014 ± 0.014 arbitrary units (AU), after 0.178 ± 0.339 AU; n = 8, P = 0.0078]. The dopamine-dependent 300-Hz rhythm probably reflects a bistable compound nuclear activity and supports high-resolution information processing in the basal ganglia circuit. An absent 300-Hz subthalamic rhythm could be a pathophysiological clue in Parkinson’s disease. The 300-Hz rhythm also provides the rationale for an excitatory—and not only inhibitory—interpretation of DBS mechanism of action in humans.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Y. Guo, J. E. Rubin, C. C. McIntyre, J. L. Vitek, and D. Terman Thalamocortical Relay Fidelity Varies Across Subthalamic Nucleus Deep Brain Stimulation Protocols in a Data-Driven Computational Model J Neurophysiol, March 1, 2008; 99(3): 1477 - 1492. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Foffani and A. Priori Deep brain stimulation in Parkinson's disease can mimic the 300 Hz subthalamic rhythm Brain, December 1, 2006; 129(12): e59 - e59. [Full Text] [PDF]
|
|
|
|
|
|
W. Meissner, A. Leblois, A. Benazzouz, and T. Boraud Reply to: Deep brain stimulation in Parkinson's disease can mimic the 300 Hz subthalamic rhythm Subthalamic high-frequency stimulation drives subthalamic oscillatory activity at stimulation frequency while firing rate is reduced Brain, December 1, 2006; 129(12): e60 - e60. [Full Text] [PDF]
|
|
|
|
|
|
F. Alonso-Frech, I. Zamarbide, M. Alegre, M. C. Rodriguez-Oroz, J. Guridi, M. Manrique, M. Valencia, J. Artieda, and J. A. Obeso Slow oscillatory activity and levodopa-induced dyskinesias in Parkinson's disease Brain, July 1, 2006; 129(7): 1748 - 1757. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Plaha, Y. Ben-Shlomo, N. K. Patel, and S. S. Gill Stimulation of the caudal zona incerta is superior to stimulation of the subthalamic nucleus in improving contralateral parkinsonism Brain, July 1, 2006; 129(7): 1732 - 1747. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Klostermann, M. Wahl, F. Marzinzik, G.-H. Schneider, A. Kupsch, and G. Curio Mental chronometry of target detection: human thalamus leads cortex Brain, April 1, 2006; 129(4): 923 - 931. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Marceglia, G. Foffani, A. M. Bianchi, G. Baselli, F. Tamma, M. Egidi, and A. Priori Dopamine-dependent non-linear correlation between subthalamic rhythms in Parkinson's disease J. Physiol., March 15, 2006; 571(3): 579 - 591. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G Foffani, A. M Bianchi, G Baselli, and A Priori Movement-related frequency modulation of beta oscillatory activity in the human subthalamic nucleus J. Physiol., October 15, 2005; 568(2): 699 - 711. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. M. Halliday, V. Macdonald, and J. M. Henderson A comparison of degeneration in motor thalamus and cortex between progressive supranuclear palsy and Parkinson's disease Brain, October 1, 2005; 128(10): 2272 - 2280. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Silberstein, A. Pogosyan, A. A. Kuhn, G. Hotton, S. Tisch, A. Kupsch, P. Dowsey-Limousin, M. I. Hariz, and P. Brown Cortico-cortical coupling in Parkinson's disease and its modulation by therapy Brain, June 1, 2005; 128(6): 1277 - 1291. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G Foffani, G Ardolino, B Meda, M Egidi, P Rampini, E Caputo, G Baselli, and A Priori Altered subthalamo-pallidal synchronisation in parkinsonian dyskinesias J. Neurol. Neurosurg. Psychiatry, March 1, 2005; 76(3): 426 - 428. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Foffani, A. Priori, R. Chen, and G. Paradiso Involvement of the human subthalamic nucleus in movement preparation Neurology, July 13, 2004; 63(1): 195 - 196. [Full Text]
|
|